Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Antoine Bondue, Eloisa Arbustini, Anna Monica Bianco, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 10, pp. 1287-1303
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8803
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1516
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy
Johann Bauersachs, Tobias König, Peter van der Meer, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 7, pp. 827-843
Open Access | Times Cited: 338
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 3, pp. 272-285
Open Access | Times Cited: 240
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study
João B. Augusto, Rocío Eirós, Eleni Nakou, et al.
European Heart Journal - Cardiovascular Imaging (2019)
Open Access | Times Cited: 183
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 89
Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease
Oriana Strianese, Francesca Rizzo, Michele Ciccarelli, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 747-747
Open Access | Times Cited: 124
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases
Ulf Landmesser, Wolfgang Poller, Sotirios Tsimikas, et al.
European Heart Journal (2020) Vol. 41, Iss. 40, pp. 3884-3899
Open Access | Times Cited: 80
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 15, pp. 3016-3051
Open Access | Times Cited: 55
Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know
Upasana Tayal, James S. Ware, Neal K. Lakdawala, et al.
European Heart Journal (2021) Vol. 42, Iss. 24, pp. 2384-2396
Open Access | Times Cited: 53
A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy
Max Catchpool, Jay Ramchand, Melissa Martyn, et al.
Genetics in Medicine (2019) Vol. 21, Iss. 12, pp. 2815-2822
Open Access | Times Cited: 51
Familial Dilated Cardiomyopathy
Stacey Peters, Renée Johnson, Samuel Birch, et al.
Heart Lung and Circulation (2019) Vol. 29, Iss. 4, pp. 566-574
Open Access | Times Cited: 45
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
Rudolf A. de Boer, Stéphane Heymans, Johannes Backs, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 406-420
Open Access | Times Cited: 39
Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management
Haran Yogasundaram, Waleed Alhumaid, Tara Dzwiniel, et al.
Canadian Journal of Cardiology (2021) Vol. 37, Iss. 4, pp. 547-559
Closed Access | Times Cited: 33
Targeting fibrosis in the failing heart with nanoparticles
Fabiana Passaro, Carlo G. Tocchetti, Gaia Spinetti, et al.
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 461-481
Closed Access | Times Cited: 33
Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity
Silvia Fanti, Edward R. Stephenson, Etel Rocha‐Vieira, et al.
Circulation (2022) Vol. 146, Iss. 25, pp. 1930-1945
Open Access | Times Cited: 24
Dilated Cardiomyopathy: A Comprehensive Approach to Diagnosis and Risk Stratification
André Ferreira, V Ferreira, Miguel Marques Antunes, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 834-834
Open Access | Times Cited: 14
Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology
María Calderón‐Domínguez, Thalía Belmonte, Maribel Quezada-Feijoó, et al.
Translational research (2019) Vol. 215, pp. 86-101
Open Access | Times Cited: 36
Dilated cardiomyopathies and non-compaction cardiomyopathy
Anja Hänselmann, Christian Veltmann, Johann Bauersachs, et al.
Herz (2020) Vol. 45, Iss. 3, pp. 212-220
Open Access | Times Cited: 35
Genetic Animal Models for Arrhythmogenic Cardiomyopathy
Brenda Gerull, Andreas Brodehl
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 35
Overview of Cardiomyopathies in Childhood
Anika Rath, Robert G. Weintraub
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 32
Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
Kyung‐Hee Kim, Naveen L. Pereira
Korean Circulation Journal (2021) Vol. 51, Iss. 10, pp. 797-797
Open Access | Times Cited: 30
Incidence and Impact of Myocarditis in Genetic Cardiomyopathies: Inflammation as a Potential Therapeutic Target
Yu. A. Lutokhina, E. V. Zaklyazminskaya, Е А Коган, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 51-51
Open Access
Genotype-phenotype insights of pediatric dilated cardiomyopathy
Ying Dai, Yan Wang, Youfei Fan, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Two Years Transplant-Free Survival After LVAD Explantation in a Titin Truncating Variant Carrier With Peripartum Cardiomyopathy and Cardiogenic Shock
Rita Godinho, Anna Nowacka, Zahurul A. Bhuiyan, et al.
Circulation Heart Failure (2025)
Closed Access
Page 1 - Next Page

Scroll to top